| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.029 | 29.033 | 31.796 | 30.684 | 29.690 | 17.718 | 24.117 | 23.721 | 20.313 | 7.068 |
| Total Income - EUR | 36.598 | 30.231 | 32.063 | 30.936 | 29.920 | 17.813 | 24.161 | 24.105 | 20.422 | 7.170 |
| Total Expenses - EUR | 35.332 | 29.074 | 32.576 | 29.640 | 29.018 | 16.568 | 18.014 | 18.704 | 19.390 | 6.126 |
| Gross Profit/Loss - EUR | 1.266 | 1.157 | -514 | 1.297 | 902 | 1.244 | 6.147 | 5.401 | 1.032 | 1.044 |
| Net Profit/Loss - EUR | 185 | 266 | -1.468 | 467 | 605 | 840 | 5.423 | 4.689 | 643 | 844 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oradentmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 16.312 | 11.672 | 13.137 | 8.029 | 10.841 | 11.498 | 14.550 | 12.708 | 7.436 | 4.751 |
| Inventories | 1.419 | 1.552 | 1.502 | 1.810 | 1.530 | 1.501 | 1.467 | 1.398 | 1.394 | 1.386 |
| Receivables | 14.472 | 9.443 | 6.196 | 4.988 | 9.102 | 9.611 | 11.096 | 9.047 | 1.380 | 1.780 |
| Cash | 421 | 676 | 5.439 | 1.231 | 209 | 386 | 1.987 | 2.262 | 4.662 | 1.586 |
| Shareholders Funds | -9.482 | -9.119 | -10.433 | -9.774 | -8.980 | -7.970 | -2.370 | 2.312 | 2.948 | 3.136 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25.794 | 20.791 | 23.570 | 17.803 | 19.821 | 19.468 | 16.920 | 10.395 | 4.488 | 1.615 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Oradentmed S.r.l.